96
Senior
Executive Team
Giles Coley
Dechra Veterinary Products
International Group Director
Background:
Giles joined Dechra in January
1999 as sales and marketing
manager for Arnolds Veterinary
Products, having previously spent
14 years primarily involved in dairy
farming business consultancy.
During his time at Dechra he
has been responsible for the
launch and market development
of a number of our key brands,
including Vetoryl. Giles has also
been an integral member of the
teams that ensured fast and
smooth integrations of several of
our acquisitions, and in particular
as lead in the integration of Apex
in 2016 and Venco in 2019.
In his role of Dechra Veterinary
Products International Group
Director, his responsibilities are
extremely varied and involve
managing and growing our
existing business through APAC
and South American business
and distribution partners, as
well as further developing our
Dechra International strategy
through product registrations
and market development. Giles
has a BSc degree in Agricultural
Technology.
Giles is located in Sansaw, UK.
Pets:
Mike Eldred
President North America
Background:
Mike joined Dechra in 2004
and is responsible for Dechra
Veterinary Products' North
American business. Mike has
more than 25 years' experience
in the animal health sector,
having held senior positions in
business development, sales and
operations at Virbac Corporation,
Fort Dodge Animal Health and
Sanofi Animal Health. As our
first employee in the USA, he
has built the North American
commercial team to greater than
250 employees and $400 million
in revenue. Mike has also been
involved in several commercial
agreements and acquisitions for
the Group including Pharmaderm,
DermaPet, Putney, Ampharmco
and Med-Pharmex. Mike has a BA
and MBA in Business.
Mike is located in Overland Park,
Kansas, USA.
Pets:
Katy Clough
Chief People Officer
Background:
Katy joined Dechra in April 2014
from AppSense Ltd where she
was the Vice President of HR
Europe and Rest of the World.
With over 15 years' experience
operating at Director level
within Software, Health, Travel
and Finance industries, Katy
brings with her a wealth of HR
expertise gained in both blue
chip corporates and smaller
entrepreneurial companies.
She has strong international,
leadership and M&A experience
and has taken responsibility for
driving the global people agenda
for the Dechra Group.
Katy is located at Head Office,
Northwich, UK.
Pets:
Melanie Hall
Company Secretary
Committee Membership:
Disclosure.
Background:
Melanie joined Dechra in
January 2010 as the Assistant
Company Secretary, and was
promoted to Deputy Company
Secretary in May 2015, and
Company Secretary in July 2017.
Prior to joining Dechra, she has
gained over 25 years' experience
in various company secretarial
roles including at GKN plc, TRW
Automotive Inc and Pendragon
PLC. Melanie is a Fellow of the
Chartered Governance Institute.
Melanie is responsible for the
Company Secretarial, Compliance
and Legal team.
Melanie is located at Head Office
in Northwich, UK.
Pets:
Milton McCann
Group Manufacturing and
Supply Director
Background:
Milton was appointed as Group
Manufacturing & Supply Director
on 1 April 2021, following 11 months
as Interim Group Manufacturing
& Supply Director. He joined
Dechra in January 2016 as Group
Manufacturing Finance Director. In
February 2019, he was the Interim
Site Director at our Skipton Facility
until being appointed as Group
Supply Chain and Procurement
Director, Dechra Pharmaceuticals
Manufacturing & Supply in October
2019.
Before joining Dechra, Milton
had senior financial roles in
different manufacturing industries
including coatings, adhesives and
chemicals. Just prior to joining
Dechra he worked for Aramark
in the food and facilities services
sector.
Milton is responsible for our
internal sites in Europe and USA,
and external manufacturing sites
globally.
Milton is located at Head Office
in Northwich, UK.
Pets:
None
Patrick Meeus
Chief Scientific Officer
Background:
Patrick joined Dechra in July 2022
and has over 30 years' experience
in animal health covering vaccine,
small molecule and diagnostics
product development across
all animal species. He also
brings substantial international
experience having lived and
worked in academia and industry
on four different continents. In
2004 Patrick joined Pfizer Animal
Health, now Zoetis, where he led
a wide range of teams, projects
and strategic initiatives from
early discovery through product
development and launch. He
joined Elanco in 2018 as the
Senior/Executive Director of
Companion Animal Product
Development.
Patrick has a Veterinary Degree
from the University of Gent
(Belgium), a PhD in Infectious
Diseases from the University of
Florida (USA) and was a founding
Diplomate of both the European
Veterinary Parasitology College
and the American College of
Veterinary Microbiologists-
Parasitology.
Patrick is currently based in Basel,
Switzerland.
Pets:
Jamie Adams*
Chief Information Officer
Background:
Jamie joined Dechra in June 2022
as Chief Information Officer. Prior
to joining, he held the same role
for Scapa plc, a global healthcare
and industrial products group
and has gained over 25
years' experience in various IT
leadership roles in large scale
pharmaceutical & medical device
organisations including Smith &
Nephew and AstraZeneca.
Jamie leads the global IT team
and is responsible for IT Strategy
development and execution,
including all IT change &
innovation activity as well as core
IT service provision. He has an
MBA from Durham University and
a BSc (Hons) degree in Business &
IT from Northumbria University.
He is located at Head Office,
Northwich, UK.
Pets:
* Appointed to the SET on 1 July 2023.
The Senior Executive Team
(SET) was established
in 2013 to lead the
development and
implementation of the
business strategy. The
SET is led by the Chief
Executive Officer and is
comprised of the three
Executive Directors and
the Business Directors
responsible for leading
each of the Group's
key functions. The SET
is scheduled to meet
formally four times
a year to discuss the
implementation of the
strategy, share best
practice and provide
updates on their business
or function as well as
sharing market trends
which impact the
business.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Dechra Pharmaceuticals plc published this content on 17 October 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 17 October 2023 10:56:06 UTC.